Cytori Therapeutics, Inc. (USA) (NASDAQ:CYTX)
CAPS Rating:
A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.
RSS Headlines
Fool UK
Recs
It's broke, its main partner is nearly broke, and isn't near any product.